- FY 2025 revenue estimated at €8,001 million – or €8,030 million at September 30 currency, in line with target
- Inflexion point in top line trajectory reached in Q4 2025: quarter-on-quarter improvement in estimated Group organic revenue performance, to -9.3% yoy
- Q4 2025 revenue estimated at €2,004 million
- Atos Strategic Business Unit (SBU) estimated revenue down –9% organically (vs –19.3% in Q3 2025) to €1,738 million
- Eviden SBU estimated revenue of €265 million, a 11.2% decrease on an organic basis
- FY 2025 estimated net change in cash[1] limited to c. €-327 million, above target
- Delivered without any usage of account receivable factoring or specific optimization on trade payables
- Including estimated restructuring impact of €431 million
- Strong liquidity position at year-end at €1,707 million
- Q4 2025 book-to-bill at 122%, in line with expected acceleration in year-end order entry level
- Atos SBU at 106%, driven by strong performance in North America, Germany and Benelux
- Eviden SBU at 229%, including the signature of the Alice Recoque supercomputer contract in HPC
- FY 2025 operating margin expected to exceed target, at above €340m (representing above 4% of revenues)
- Longer-term ambitions unchanged
This version cancels and supersedes the version of the press release issued and filed with the AMF on January 21 at 8:00 a.m. (Paris time). This follows the correction of an error in the date indicated in the subparagraph “Liquidity position” (“net change in cash for FY 2025,” and not “net change in cash for the quarter” as stated in the initial version).
